The upregulation of CD52 in CD4+ T cells in AD impairs antigen-specific T cell responses and thus potentially contributes to immunoparesis in AD, which leads to an increase in the risk of infection and mortality. This evidence concerns the gene CD52 and Alzheimer disease.